Statistics for AxoGen (id:5348 AXGN)

Valuation metrics

Market cap

556.26M

Enterprise value

603.04M

Trailing P/E (ttm)

-25.29

Forward P/E

40.77

PEG ratio

40.77

Price/Sales (ttm)

3.08

Price/Book (mrq)

5.60

Enterprise Value/Revenue

3.33

Enterprise Value/EBITDA

-326.32

Overview

Shares outstanding

44.01M

Float

38.54M

Shares short

1.13M

% Held by insiders

0.06%

% Held by institutions

0.85%

Average volume (10 days)

567.51K

Average volume (90 days)

Price summary

52-Week low

5.55

52-Week high

15.90

52-Week change

54.26%

Beta

1.13

50-Day moving average

13.79

200-Day moving average

9.82

Dividends and splits

Forward annual dividend rate

4.00

Forward annual dividend yield

0.31

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

February 12th, 2010

Ex-dividend date

January 27th, 2010

Last split factor

2:1

Last split date

July 11th, 1994

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-7.91%

Operating margin

-0.65%

Operational effectiveness

Return on assets

-2.75%

Return on equity

-14.51%

Income statement

Revenue (ttm)

4.16

Revenue per share (ttm)

4.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

127.87M

EBITDA

-1,848,000.00

Net income to common (ttm)

-14,307,000.00

Diluted EPS (ttm)

-0.33

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

24.53M

Total cash per share (mrq)

0.56

Total debt (mrq)

71.31M

Total Debt/Equity (mrq)

71.73

Current ratio (mrq)

374.50%

Book value per share (mrq)

2.26

Cash flow

Cash flow statement

-4,411,000.00

Levered free cash flow (LFCF)

-4,372,250.00